Boots开始在17个英国城市进行牲畜重量损失刺拳试验, 提供面对面获得Wegovy等药品的机会。 Boots starts in-store weight-loss jab trials in 17 UK cities, offering face-to-face access to drugs like Wegovy.

Boots在联合王国的17个地点(包括伦敦、曼彻斯特和爱丁堡)启动了一次室内体重损失刺拳服务试验,标志着在高街道药店首次提供Mounjaro和Wegovy等治疗。 Boots has launched a trial of in-store weight-loss jab services in 17 UK locations, including London, Manchester, and Edinburgh, marking the first time treatments like Mounjaro and Wegovy are available in high street pharmacies. 客户可以接受与药剂师的私人咨询,以便根据健康历史、体重和BMI评估资格,提供在线处方的面对面替代。 Customers can receive private consultations with pharmacists to assess eligibility based on health history, weight, and BMI, offering a face-to-face alternative to online prescriptions. 这项服务补充了Boots现有的数字平台,旨在改善获得由医疗监督的体重管理护理的机会,特别是为那些更愿意亲自提供支助的人提供这种服务。 The service complements Boots’ existing digital platform and aims to improve access to medically supervised weight management care, particularly for those who prefer in-person support. 最低剂量Wegovy的价格从99.97英镑开始。 Prices start at £99.97 for the lowest dose of Wegovy.